🔎 Trials Near Me

Gara Jalqabaatti › Dermatitis Atopic (Eczema) › Oregon › Portland

Qorannoo klinikaalii Dermatitis Atopic (Eczema) Portland, OR keessatti

Qorannoo 5 Dermatitis Atopic (Eczema) f Portland fi naannoo isaa (kilomeetira 30 keessatti) hirmaatuu jiru. Qorannoo banaa eenyu akka hirmaatu fi akkamitti garee qorannoo akka quunnaman ilaali.

Takkalaa qorannoo (Ingiliffa)

Qorannoo hirmaatuu barbaadduu? Fuula kana jalatti agarsiisi — $99 guyyaa 30f →

A Long-term Safety and Efficacy Study Evaluating APG777 in Atopic Dermatitis

Namoota walitti qabaa jiraSadarkaa 2
  • Investigational Site, Portland
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 23-Ful-2026 · NCT07003425

A Study to Evaluate the Efficacy and Safety of IMG-007 in Adult Participants With Moderate-to-Severe Atopic Dermatitis

Namoota walitti qabaa jiraSadarkaa 2
  • Inmagene Site 3, Portland
Umuriin 18 hanga 74 · Saalaa hunda · Haaromfame 12-Hag-2026 · NCT07037901

A Study to Assess Adverse Events and Change in Disease Activity Comparing Oral Upadacitinib to Subcutaneous Dupilumab in Children From 2 to Less Than 12 Years of Age With Moderate to Severe Atopic Dermatitis

Namoota walitti qabaa jiraSadarkaa 3
  • Oregon Health and Science University /ID# 266483, Portland
Umuriin 2 hanga 11 · Saalaa hunda · Haaromfame 06-Hag-2026 · NCT06461897

A Trial to Evaluate the Efficacy and Safety of Tralokinumab in Combination With Topical Corticosteroids in Children and Infants With Moderate-to-severe Atopic Dermatitis

Namoota walitti qabaa jiraSadarkaa 3
  • Leo Pharma Investigational site, Portland
6 Months – 11 Years · Saalaa hunda · Haaromfame 07-Ado-2026 · NCT06311682

A Study of Upadacitinib in Adult Participants With Moderate-to-Severe Atopic Dermatitis and Inadequate Response to Dupilumab

Namoota walitti qabaa jiraSadarkaa 3
  • Oregon Health and Science University /ID# 263736, Portland
Umuriin 18 hanga 63 · Saalaa hunda · Haaromfame 06-Ado-2026 · NCT06389136

Qorannoo Dermatitis Atopic (Eczema) magaalota biroo keessatti

Qorannoo biroo Portland keessatti

Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.